Innovent Biologics, Inc. (HKG:1801)
Hong Kong
· Delayed Price · Currency is HKD 52.30
-2.00 (-3.68%)
May 7, 2025, 4:08 PM HKT
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of 86.20 billion as of May 7, 2025. Its market cap has increased by 41.66% in one year.
Market Cap
86.20B
Enterprise Value
80.82B
Revenue
10.03B
Ranking
n/a
PE Ratio
n/a
Stock Price
52.30
Market Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 18.54B to 86.20B, an increase of 364.96%. That is a compound annual growth rate of 26.58%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 213.88B |
| Hansoh Pharmaceutical Group Company | 145.08B |
| JD Health International | 122.47B |
| WuXi Biologics | 97.88B |
| Alibaba Health Information Technology | 82.83B |
| Akeso | 78.81B |
| Sichuan Kelun-Biotech Biopharmaceutical | 78.13B |
| Sino Biopharmaceutical | 71.04B |